PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
39,830,013
Share change
-3,535,450
Total reported value
$41,817,000
Price per share
$1.05
Number of holders
78
Value change
-$7,278,435
Number of buys
33
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q1 2016

As of 31 Mar 2016, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,830,013 shares. The largest 10 holders included Broadfin Capital, LLC, MORGAN STANLEY, venBio Select Advisor LLC, Stonepine Capital Management, LLC, Point72 Asset Management, L.P., Elk Creek Partners, LLC, Aisling Capital LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.